Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results
Q4 and FY Test volume increase 21% and 17% year-over-year ●Q4 and FY Volume, Revenue, and Profitability at all-time record levels ...
Interpace Biosciences, Inc.: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results
Q4 and FY Volume, Revenue, and Profitability at all-time record levels PARSIPPANY, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences ...
News Medical on MSN18h
Researchers develop T cell growth method that enhances cancer-fighting ability in melanoma model
Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the ...
New study uncovers how gliomas disrupt brain function and points to rapid therapeutic reversal
A study led by Dr. Peter Canoll's lab, in collaboration with researchers at Columbia University Irving Medical Center, Zuckerman Institute, and Irving Institute for Cancer Dynamics, along with ...